Skip to main content

The National HIV/AIDS Strategy

In 1981, the CDC reported the first U.S. cases of HIV infection in California and New York, where clusters of young gay men were diagnosed with unusual diseases like Kaposi's Sarcoma.

Over the next few years, new community-based organizations advocated for increased funding into research on testing and treatment, and the first antiretroviral drug was approved by the U.S. Food and Drug Administration (FDA) in 1987. The next year, the first state and city Health Resources and Services Administration (HRSA) grants for HIV planning were awarded, a program that would later become the Ryan White CARE Act.

In 2010, the National HIV/AIDS Strategy, a five-year plan that outlines how the nation will continue its response to the HIV epidemic, was launched. A new version called the National HIV/AIDS Strategy for the United States: Updated to 2020 was released in 2015. The plan helps to coordinate and focus the efforts of all agencies and organizations interested in preventing and treating HIV/AIDS.

Resources to Learn More

National HIV/AIDS Strategy for the United States: Updated to 2020
This report is an update to the first National HIV/AIDS Strategy for the United States released in 2010. The Strategy outlines a vision and goals for the nation moving forward to address HIV/AIDS prevention and treatment. The report also discusses the progress made and lessons learned since the initial release in 2010. The report documents a path forward for preventing and treating HIV/AIDS and highlights success stories.
Organization(s): The White House
Date: 7/2015